ENOCHIAN BIOSCIENCES INC's ticker is ENOB and the CUSIP is 29350E104. A total of 22 filers reported holding ENOCHIAN BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $47,065 | +688.9% | 10,529 | 0.0% | 0.00% | – |
| Q2 2023 | $5,966 | -88.1% | 10,529 | -80.9% | 0.00% | – |
| Q1 2023 | $50,335 | -11.2% | 55,005 | 0.0% | 0.00% | – |
| Q4 2022 | $56,655 | -42.8% | 55,005 | 0.0% | 0.00% | – |
| Q3 2022 | $99,000 | +4.2% | 55,005 | +11.3% | 0.00% | – |
| Q2 2022 | $95,000 | +9.2% | 49,423 | +369.4% | 0.00% | – |
| Q1 2022 | $87,000 | +13.0% | 10,529 | 0.0% | 0.00% | – |
| Q4 2021 | $77,000 | +8.5% | 10,529 | 0.0% | 0.00% | – |
| Q3 2021 | $71,000 | +24.6% | 10,529 | -7.5% | 0.00% | – |
| Q2 2021 | $57,000 | -69.0% | 11,377 | -78.1% | 0.00% | – |
| Q1 2021 | $184,000 | +19.5% | 52,015 | -0.3% | 0.00% | – |
| Q4 2020 | $154,000 | -19.4% | 52,164 | -2.1% | 0.00% | – |
| Q3 2020 | $191,000 | -13.6% | 53,291 | +1.2% | 0.00% | – |
| Q2 2020 | $221,000 | +97.3% | 52,685 | +40.0% | 0.00% | – |
| Q1 2020 | $112,000 | -5.9% | 37,621 | +58.2% | 0.00% | – |
| Q4 2019 | $119,000 | – | 23,778 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 1,341,663 | $6,668,000 | 0.94% |
| Tibra Equities Europe Ltd | 41,900 | $208,000 | 0.06% |
| Virtu Financial LLC | 68,007 | $338,000 | 0.03% |
| Ergoteles LLC | 47,984 | $238,000 | 0.01% |
| Jacobi Capital Management LLC | 4,500 | $22,000 | 0.00% |
| HRT FINANCIAL LP | 41,058 | $204,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 14,099 | $72,000 | 0.00% |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 47,691 | $237,000 | 0.00% |
| JANE STREET GROUP, LLC | 11,948 | $59,000 | 0.00% |
| UBS Group AG | 260 | $1,000 | 0.00% |